Trials / Conditions / Antiphospholipid Antibody Syndrome
Antiphospholipid Antibody Syndrome
7 registered clinical trials studyying Antiphospholipid Antibody Syndrome.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients NCT02139072 | University of Florida | — |
| Completed | Rivaroxaban for Antiphospholipid Antibody Syndrome NCT02116036 | St. Joseph's Healthcare Hamilton | Phase 4 |
| Completed | Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody NCT01029587 | Johns Hopkins University | Phase 2 |
| Completed | CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen NCT01762891 | Hospital Universitario Pedro Ernesto | N/A |
| Terminated | Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT NCT00564174 | Mount Sinai Hospital, Canada | N/A |
| Completed | Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphosphol NCT00010400 | Johns Hopkins University | N/A |
| Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity NCT03941184 | Mayo Clinic | — |